Autologous tumor-derived heat-shock protein peptide complex-96 (HSPPC-96) in patients with metastatic melanoma

被引：0
|
作者：
Omar Eton
Merrick I Ross
Mary Jo East
Paul F Mansfield
Nicholas Papadopoulos
Julie A Ellerhorst
Agop Y Bedikian
Jeffrey E Lee
机构：
[1] The University of Texas MD Anderson Cancer Center,Department of Melanoma Medical Oncology
[2] The University of Texas MD Anderson Cancer Center,Department of Surgical Oncology
[3] The University of Texas MD Anderson Cancer Center,Department of Experimental Therapeutics
来源：
Journal of Translational Medicine | / 8卷
关键词：
Melanoma; Major Histocompatibility Complex Class; Adjuvant Setting; ELISPOT Assay; Autologous Tumor Cell;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Leukemia: Derived heat shock protein gp96-peptide complex contribution to T cell and dendritic cell activation
    Shen, Dan
    Xu, Chongqin
    Fang, Han
    Xie, Junjun
    YueD, S.
    Jin, Jie
    Tong, Xiangming
    AFRICAN JOURNAL OF BIOTECHNOLOGY, 2011, 10 (30): : 5760 - 5768
  • [42] Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: The C-100-21 study group (vol 26, pg 955, 2008)
    Testori, A.
    Richards, J.
    Whitman, E.
    Mann, G. B.
    Lutzky, J.
    Camacho, L.
    Parmiani, G.
    Tosti, G.
    Kirkwood, J. M.
    Hoos, A.
    Yuh, L.
    Gupta, R.
    Srivastava, P. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (22) : 3819 - 3819
  • [43] Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: A pilot study
    Janetzki, S
    Palla, D
    Rosenhauer, V
    Lochs, H
    Lewis, JJ
    Srivastava, PK
    INTERNATIONAL JOURNAL OF CANCER, 2000, 88 (02) : 232 - 238
  • [44] Phase II Trial of Adjuvant Immunotherapy with Autologous Tumor-derived Gp96 Vaccination in Patients with Gastric Cancer
    Zhang, Kecheng
    Peng, Zheng
    Huang, Xiaohui
    Qiao, Zhi
    Wang, Xinxin
    Wang, Ning
    Xi, Hongqing
    Cui, Jianxin
    Gao, Yunhe
    Huang, Xijian
    Gao, Hua
    Wei, Bo
    Chen, Lin
    JOURNAL OF CANCER, 2017, 8 (10): : 1826 - 1832
  • [45] Experience with heat shock protein-peptide complex 96 vaccine therapy in patients with indolent non-hodgkin lymphoma
    Oki, Yasuhiro
    McLaughlin, Peter
    Fayad, Luis E.
    Pro, Barbara
    Mansfield, Paul F.
    Clayman, Gary L.
    Medeiros, L. Jeffrey
    Kwak, Larry W.
    Srivastava, Pramod K.
    Younes, Anas
    CANCER, 2007, 109 (01) : 77 - 83
  • [46] Generation of tumor-specific cytotoxic T lymphocytes in multiple myeloma using dendritic cells pulsed with tumor-derived heat shock protein gp96.
    Yi, Q
    Qian, JF
    Xie, J
    Wang, SQ
    Freeman, ME
    Barlogie, B
    BLOOD, 2004, 104 (11) : 673A - 673A
  • [47] Phase II trial of adjuvant immunotherapy with autologous tumor-derived Gp96 vaccination in patients with gastric cancer.
    Chen, Lin
    Zhang, Kecheng
    Peng, Zheng
    Wei, Bo
    Xi, Hongqing
    Wang, Xinxin
    Wang, Ning
    Cui, Jianxin
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [48] Tumor-derived inducible heat-shock protein 70 (HSP70) is an essential component of anti-tumor immunity
    K Dodd
    S Nance
    M Quezada
    L Janke
    J B Morrison
    R T Williams
    H M Beere
    Oncogene, 2015, 34 : 1312 - 1322
  • [49] Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations (vol 278, pg 117, 1997)
    Tamura, Y
    SCIENCE, 1999, 283 (5405) : 1118 - 1118
  • [50] Tumor-derived inducible heat-shock protein 70 (HSP70) is an essential component of anti-tumor immunity
    Dodd, K.
    Nance, S.
    Quezada, M.
    Janke, L.
    Morrison, J. B.
    Williams, R. T.
    Beere, H. M.
    ONCOGENE, 2015, 34 (10) : 1312 - 1322
12345